BlackRock Inc. Sells 4,844,135 Shares of Aetna Inc (AET)

BlackRock Inc. lessened its holdings in Aetna Inc (NYSE:AET) by 16.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,146,918 shares of the company’s stock after selling 4,844,135 shares during the period. BlackRock Inc. owned approximately 7.39% of Aetna worth $4,355,861,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. Alpine Associates Management Inc. bought a new stake in Aetna during the fourth quarter worth about $159,933,000. Orbimed Advisors LLC grew its stake in Aetna by 57.3% during the third quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after buying an additional 508,600 shares during the last quarter. CI Investments Inc. bought a new stake in Aetna during the fourth quarter worth about $87,552,000. Governors Lane LP bought a new stake in Aetna during the fourth quarter worth about $68,223,000. Finally, Point72 Asset Management L.P. grew its stake in Aetna by 233.9% during the third quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock worth $68,271,000 after buying an additional 300,753 shares during the last quarter. 87.10% of the stock is owned by hedge funds and other institutional investors.

Several brokerages have weighed in on AET. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Jefferies Group reissued a “hold” rating and set a $205.00 price target on shares of Aetna in a research note on Wednesday, January 31st. Credit Suisse Group increased their price target on shares of Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a research note on Wednesday, January 31st. Citigroup cut shares of Aetna from a “buy” rating to a “neutral” rating and increased their price target for the company from $187.89 to $212.00 in a research note on Wednesday, January 31st. Finally, Cowen reissued a “buy” rating and set a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. Ten investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $185.94.

Aetna Inc (NYSE:AET) opened at $177.17 on Friday. Aetna Inc has a 52 week low of $124.83 and a 52 week high of $194.40. The stock has a market cap of $57,793.63, a P/E ratio of 30.81, a price-to-earnings-growth ratio of 1.43 and a beta of 0.60. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The firm had revenue of $14.74 billion for the quarter, compared to analysts’ expectations of $14.79 billion. During the same period last year, the firm earned $0.08 earnings per share. The business’s revenue for the quarter was down 6.2% on a year-over-year basis. equities research analysts predict that Aetna Inc will post 10.99 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Thursday, January 11th were paid a $0.50 dividend. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. Aetna’s payout ratio is presently 34.78%.

COPYRIGHT VIOLATION NOTICE: “BlackRock Inc. Sells 4,844,135 Shares of Aetna Inc (AET)” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/16/blackrock-inc-sells-4844135-shares-of-aetna-inc-aet.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply